These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32041563)

  • 21. Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).
    Panni RZ; Lopez-Aguiar AG; Liu J; Poultsides GA; Rocha FG; Hawkins WG; Strasberg SM; Trikalinos NA; Maithel S; Fields RC;
    J Surg Oncol; 2019 Sep; 120(4):632-638. PubMed ID: 31339198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
    Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
    Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
    Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
    Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.
    Harimoto N; Hoshino K; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Suzuki H; Arakawa K; Hirai K; Fukazawa T; Ikota H; Shirabe K
    Pancreatology; 2019 Sep; 19(6):897-902. PubMed ID: 31409525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma.
    Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
    Anticancer Res; 2014 Sep; 34(9):5163-8. PubMed ID: 25202109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    Sugawara T; Ban D; Nishino J; Watanabe S; Maekawa A; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanaka S; Tanabe M
    PLoS One; 2021; 16(4):e0249885. PubMed ID: 33844700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
    Winter JM; Jiang W; Basturk O; Mino-Kenudson M; Fong ZV; Tan WP; Lavu H; Vollmer CM; Furth EE; Haviland D; Klimstra DS; Jarnagin WR; Lillemoe KD; Yeo CJ; Fernandez-Del Castillo C; Allen PJ
    Ann Surg; 2016 Apr; 263(4):793-801. PubMed ID: 26135696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
    Chen XQ; Xue CR; Hou P; Lin BQ; Zhang JR
    World J Gastroenterol; 2019 Sep; 25(33):4970-4984. PubMed ID: 31543687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucinous cystic neoplasms of the pancreas in the modern era. Experience with 707 patients.
    Ahmad M; Maegawa FB; De La Rosa E; Davis B; Tyroch A; Konstantinidis IT
    Am J Surg; 2020 Dec; 220(6):1433-1437. PubMed ID: 32938530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis.
    Temraz S; Mukherji D; Farhat ZA; Nasr R; Charafeddine M; Shahait M; Wehbe MR; Ghaida RA; Gheida IA; Shamseddine A
    BMC Urol; 2014 Sep; 14():76. PubMed ID: 25234356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
    Chari ST; Yadav D; Smyrk TC; DiMagno EP; Miller LJ; Raimondo M; Clain JE; Norton IA; Pearson RK; Petersen BT; Wiersema MJ; Farnell MB; Sarr MG
    Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 38. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
    Tsujita E; Ikeda Y; Kinjo N; Yamashita YI; Hisano T; Furukawa M; Taguchi KI; Morita M; Toh Y; Okamura T
    Am Surg; 2017 Jun; 83(6):610-616. PubMed ID: 28637563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.
    Nakano Y; Kitago M; Shinoda M; Abe Y; Yagi H; Hibi T; Takeuchi A; Aiura K; Itano O; Kitagawa Y
    Cancer Med; 2017 Oct; 6(10):2278-2286. PubMed ID: 28925039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma.
    Chang Y; Fu Q; Xu L; Zhou L; Liu Z; Yang Y; Lin Z; Xu J
    Tumour Biol; 2016 Apr; 37(4):4613-20. PubMed ID: 26508025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.